These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15604326)

  • 1. Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome.
    Mukherjee D; Kline-Rogers E; Fang J; Munir K; Eagle KA
    Heart; 2005 Jan; 91(1):23-6. PubMed ID: 15604326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
    Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
    Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction.
    Gulec S; Ozdol C; Rahimov U; Atmaca Y; Kumbasar D; Erol C
    J Invasive Cardiol; 2005 Nov; 17(11):589-93. PubMed ID: 16264203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
    Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
    Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation.
    Schmidt M; Johansen MB; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Baron JA; Sørensen HT
    Br J Clin Pharmacol; 2012 Jul; 74(1):161-70. PubMed ID: 22243420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
    Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
    J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
    Park Y; Jeong YH; Tantry US; Ahn JH; Kwon TJ; Park JR; Hwang SJ; Gho EH; Bliden KP; Kwak CH; Hwang JY; Kim S; Gurbel PA
    Eur Heart J; 2012 Sep; 33(17):2151-62. PubMed ID: 22507978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet reactivity and clinical outcomes in patients using CYP3A4-metabolized statins with clopidogrel in percutaneous coronary intervention.
    Park JS; Cha KS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Kim HS;
    Heart Vessels; 2017 Jun; 32(6):690-699. PubMed ID: 27904973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.
    Vinholt P; Poulsen TS; Korsholm L; Kristensen SR; Hallas J; Damkier P; Mickley H
    Thromb Haemost; 2005 Aug; 94(2):438-43. PubMed ID: 16113837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Geisler T; Zürn C; Paterok M; Göhring-Frischholz K; Bigalke B; Stellos K; Seizer P; Kraemer BF; Dippon J; May AE; Herdeg C; Gawaz M
    Eur Heart J; 2008 Jul; 29(13):1635-43. PubMed ID: 18503057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study.
    Blagojevic A; Delaney JA; Lévesque LE; Dendukuri N; Boivin JF; Brophy JM
    Pharmacoepidemiol Drug Saf; 2009 May; 18(5):362-9. PubMed ID: 19253920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
    Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
    J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison on the effects of clopidogrel, statins combination in treating coronary artery disease among the elderly patients: a retrospective cohort study].
    Gao Y; Cao J; Lu XC; Liu XF; Ma C; Fan L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):337-41. PubMed ID: 22613391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention.
    Brophy JM; Babapulle MN; Costa V; Rinfret S
    Am Heart J; 2006 Aug; 152(2):263-9. PubMed ID: 16875906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ
    Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the ticagrelor-statin interplay in the PLATO trial.
    Dinicolantonio JJ; Serebruany VL
    Cardiology; 2013; 124(2):105-7. PubMed ID: 23407140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel--statin interaction.
    Nawarskas JJ
    Cardiol Rev; 2004; 12(5):236-9. PubMed ID: 15316304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clopidogrel-statin interaction.
    Tantry US; Jeong YH; Gurbel PA
    Circ J; 2014; 78(3):592-4. PubMed ID: 24521731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.